|
DCAF7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.104200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.371800E-02 |
| Normal-vs-Stage2 |
4.349000E-01 |
| Normal-vs-Stage3 |
5.168200E-01 |
| Normal-vs-Stage4 |
7.504000E-01 |
| Stage1-vs-Stage2 |
9.781200E-01 |
| Stage1-vs-Stage3 |
7.910400E-01 |
| Stage1-vs-Stage4 |
8.604400E-01 |
| Stage2-vs-Stage3 |
8.619200E-01 |
| Stage2-vs-Stage4 |
8.981600E-01 |
| Stage3-vs-Stage4 |
9.950400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.877900E-02 |
| Normal-vs-AfricanAmerican |
5.448800E-01 |
| Normal-vs-Asian |
8.158600E-01 |
| Caucasian-vs-AfricanAmerican |
2.596800E-01 |
| Caucasian-vs-Asian |
7.560000E-01 |
| AfricanAmerican-vs-Asian |
9.890600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.955040E-01 |
| Normal-vs-Female |
3.159500E-03 |
| Male-vs-Female |
2.977900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.811000E-01 |
| Normal-vs-Extreme_Weight |
5.768400E-01 |
| Normal-vs-Obese |
2.023000E-01 |
| Normal-vs-Extreme_Obese |
4.544000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.251000E-01 |
| Normal_Weight-vs-Obese |
3.978000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.584000E-01 |
| Extreme_Weight-vs-Obese |
5.686600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.384600E-01 |
| Obese-vs-Extreme_Obese |
7.040000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.496120E-02 |
| Normal-vs-Age(41-60Yrs) |
9.955600E-04 |
| Normal-vs-Age(61-80Yrs) |
8.245400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.914300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.952400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.005700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.771500E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.163100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.574600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.038830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.315940E-03 |
| Normal-VS-Type2 PRCC |
4.230200E-01 |
| Normal-VS-KIRP CIMP |
4.668400E-01 |
| Normal-VS-Unclassified PRCC |
7.343900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.258400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.282200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.090800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.711600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.194000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.236600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.826000E-01 |
| Normal-vs-N1 |
3.744000E-01 |
| Normal-vs-N2 |
4.522000E-01 |
| N0-vs-N1 |
4.049000E-01 |
| N0-vs-N2 |
2.581800E-01 |
| N1-vs-N2 |
5.462200E-01 |
|
|
